Results 71 to 80 of about 21,804,485 (185)
The Biopharmaceutics Classification System (BCS), developed in the 1990s for oral immediate release drugs, is utilized by R&D scientists and regulators to streamline product development and regulatory approval timelines.
Jayne E. Hastedt +12 more
doaj +1 more source
Enhancing the Solubility and Dissolution Performance of Safinamide Using Salts
Safinamide (SAF) is an anti-Parkinson’s disease (PD) drug that has selective monoamine oxidase type-B (MAO-B) inhibition activity. In 2017, SAF was approved by the U.S. Food and Drug Administration (FDA) as safinamide mesylate (SAF-MS, marketed as Xadago)
Lei Gao, Qian Liu, Xian-Rui Zhang
doaj +1 more source
ABSTRACT Curcumin (CUR) is a bioactive compound with antioxidant, anti‐inflammatory, and anticancer properties, though its clinical use is limited by low bioavailability, rapid metabolism, and poor solubility. To address these challenges, our study investigates nanoencapsulated curcumin (NC‐CUR) to enhance its pharmacokinetics and therapeutic efficacy,
Ana Pozzato Funghetto‐Ribeiro +9 more
wiley +1 more source
ABSTRACT Predictive in vitro dissolution methods are crucial for anticipating in vivo drug performance, particularly for poorly soluble drugs like carbamazepine. In vitro‐in vivo correlations (IVIVC) link dissolution characteristics to pharmacokinetics, facilitating bioequivalence studies and reducing reliance on clinical trials.
Laura Carvajal Barbosa +2 more
wiley +1 more source
ABSTRACT Olverembatinib is approved in China to treat patients with chronic‐ or accelerated‐phase chronic myeloid leukemia (CML‐CP or CML‐AP) with T315I mutations and CML‐CP that is resistant and/or intolerant to first‐ and second‐generation tyrosine kinase inhibitors.
Hengbang Wang +8 more
wiley +1 more source
Recent Advances in Oral Drug Delivery Systems for BCS III Drugs
Oral drugs classified under Class III of the Biopharmaceutics Classification System (BCS) are defined by high aqueous solubility yet low intestinal permeability.
Junpeng Yu +15 more
doaj +1 more source
Aims Vutiglabridin (HSG4112) is a novel drug under clinical development for antiobesity treatment. This study aimed to evaluate the pharmacokinetics (PKs) and safety of vutiglabridin after multiple oral administrations in healthy Korean female and obese subjects and explore short‐term pharmacodynamic (PD) responses.
Sooyoun Lee +5 more
wiley +1 more source
Aerogels are well-known as the lightest material with high empty volume inside their structure. There are many advantages of using aerogel as drug carriers by supercritical CO2 (scCO2) process, including clean manufactory progress, absence of an ...
Ngoc Phan Tran +2 more
doaj +1 more source
ABSTRACT Population pharmacokinetic–pharmacodynamic (PK–PD) modeling was used to explore covariate effects on zolpidem PKs and PDs in 30 healthy Korean volunteers (15 males, 15 females) who received a single 10 mg dose. The dataset included 325 PK observations and 388 observations each for the digit symbol substitution test (DSST), choice reaction time
Hyun Chul Kim +4 more
wiley +1 more source
ABSTRACT Drug–food interactions may compromise therapeutic efficacy, particularly for life‐saving medications such as anticoagulants. Changes in gastric fluid properties, including pH modification and surface film formation, can alter drug dissolution and release. This study evaluated a potential interaction between clopidogrel and spinach and explored
Dana Sadaqa +4 more
wiley +1 more source

